Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19

New interview of the IRDiRC chair, Dr Lucia Monaco recently had with ALS News Today. COVID-19 is impacting the daily lives of every person in the planet and it is also changing the research field, however Dr. Monaco  remains confident that IRDiRC will see the approval of 1,000 new rare disease therapies by 2027 as stated in the IRDiRC new goals. We can do it! Stay safe and positive.